Abnormal Mucosal Extracellular Matrix Deposition Is Associated with Increased TGF-ß Receptor-expressing Mesenchymal Cells in a Mouse Model of ColitisChristine V. Whitinga, John F. Tarltona, Michael Baileya, Clare L. Morgana, and Paul W. Blanda,ba Division of Veterinary Pathology, Infection and Immunity, Department of Clinical Veterinary Science, University of Bristol, Bristol, United Kingdom b Department of Clinical Immunology, University of Gothenburg, Gothenburg, Sweden Correspondence to: Christine V. Whiting, Div. of Veterinary Pathology, Infection and Immunity, Dept. of Clinical Veterinary Science, University of Bristol, Bristol BS40 5DU, UK. E-mail: c.v.whiting@bris.ac.uk
Transforming growth factor-ß (TGF-ß) depresses mucosal inflammation and upregulates extracellular matrix (ECM) deposition. We analyzed TGF-ß receptors RI and RII as well as ECM components using the CD4+ T-cell-transplanted SCID mouse model of colitis. The principal change in colitis was an increased proportion of TGF-ß RII+ mucosal mesenchymal cells, predominantly (J Histochem Cytochem 51:11771189, 2003) Key Words: extracellular matrix, TGF-ß colitis, mouse model, TGF-ß receptors, intestine, wound healing
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||